S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:ESALY

Eisai (ESALY) Stock Price, News & Analysis

$61.51
-1.33 (-2.11%)
(As of 01/30/2023)
Today's Range
$61.00
$63.29
50-Day Range
$61.51
$61.51
52-Week Range
$36.88
$73.90
Volume
331,800 shs
Average Volume
60,916 shs
Market Capitalization
$17.64 billion
P/E Ratio
70.70
Dividend Yield
1.43%
Price Target
N/A
ESALY stock logo

About Eisai Stock (OTCMKTS:ESALY)

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

ESALY Stock Price History

ESALY Stock News Headlines

Eisai Co Ltd
Eisai Co Ltd 4523
“The Stock Market’s Bull Run is Far from Over” -Barrons
Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!
BIIB Mar 2024 210.000 call
BIIB Mar 2024 235.000 call
BIIB Feb 2024 227.500 call
BIIB Mar 2024 205.000 put
ESALF Eisai Co., Ltd.
“The Stock Market’s Bull Run is Far from Over” -Barrons
Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!
UTHR vs. ESALY: Which Stock Is the Better Value Option?
See More Headlines
Receive ESALY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eisai and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/04/2021
Today
3/28/2024
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:ESALY
Employees
11,322
Year Founded
N/A

Profitability

Net Income
$426.79 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.74 billion
Cash Flow
$2.68 per share
Book Value
$23.94 per share

Miscellaneous

Free Float
N/A
Market Cap
$17.64 billion
Optionable
Not Optionable
Beta
0.31
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Haruo Naito
    Chief Executive Officer & Director
  • Yasushi Okada
    COO, Representative Executive Officer & Head-China
  • Tatsuyuki Yasuno
    Chief Financial & investor Relations Officer
  • Keisuke Naito
    Executive Officer & Head-Global IT Headquarters
  • Yosuke Akita
    Chief Compliance Officer & & Head-Internal Control

Should I Buy Eisai Stock? ESALY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Eisai Co., Ltd.:

  • Eisai Co., Ltd. recently inked a $2 billion oncology deal with a China-based startup, indicating strategic expansion and potential growth opportunities in the oncology sector.
  • The company operates in the pharmaceutical industry, which is known for its stability and resilience, offering long-term investment prospects.
  • Eisai Co., Ltd. has a strong presence in Japan's consumer healthcare market, providing a diversified revenue stream and potential for steady income.
  • With a focus on prescription medicines and over-the-counter products, Eisai Co., Ltd. caters to a wide range of healthcare needs, ensuring a broad market reach.
  • Investors may find Eisai Co., Ltd.'s stock price attractive, considering recent market trends and the company's growth potential in the pharmaceutical sector.

Cons

Investors should be bearish about investing in Eisai Co., Ltd. for these reasons:

  • Eisai Co., Ltd. faces competition in the pharmaceutical industry, which could impact its market share and profitability.
  • The company's reliance on prescription medicines and over-the-counter products may expose it to regulatory risks and market fluctuations.
  • Investing in pharmaceutical companies involves inherent risks related to drug development, patent expirations, and regulatory approvals.
  • Eisai Co., Ltd.'s performance may be influenced by global economic conditions and healthcare policies, affecting its financial stability.
  • Fluctuations in currency exchange rates could impact Eisai Co., Ltd.'s international operations and financial performance.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, March 26, 2024. Please send any questions or comments about these Eisai pros and cons to contact@marketbeat.com.

ESALY Stock Analysis - Frequently Asked Questions

Should I buy or sell Eisai stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Eisai in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ESALY shares.
View ESALY analyst ratings
or view top-rated stocks.

How have ESALY shares performed in 2024?

Eisai's stock was trading at $61.51 at the start of the year. Since then, ESALY shares have increased by 0.0% and is now trading at $61.51.
View the best growth stocks for 2024 here
.

How were Eisai's earnings last quarter?

Eisai Co., Ltd. (OTCMKTS:ESALY) released its quarterly earnings data on Wednesday, August, 4th. The company reported $1.34 earnings per share for the quarter, topping analysts' consensus estimates of $1.09 by $0.25. The business had revenue of $1.82 billion for the quarter. Eisai had a trailing twelve-month return on equity of 3.86% and a net margin of 4.11%.

Is Eisai a good dividend stock?

Eisai (OTCMKTS:ESALY) pays an annual dividend of $0.88 per share and currently has a dividend yield of 1.43%. The dividend payout ratio is 101.15%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, ESALY will have a dividend payout ratio of 73.95% next year. This indicates that the company will be able to sustain or increase its dividend.

How do I buy shares of Eisai?

Shares of ESALY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ESALY) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners